Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses

Area of Science:

• Neuroscience
• Pharmacology
• Cellular Biology

Background:

• Glutamate is the primary excitatory neurotransmitter, with N-methyl-D-aspartate receptors (NMDARs) mediating crucial neural functions.
• Overactivation of NMDARs contributes to neuronal damage in neurological conditions.
• Memantine, used for Alzheimer's disease, has a good safety profile, suggesting targeted NMDAR modulation.

Purpose of the Study:

• To investigate the mechanism behind memantine's therapeutic safety by examining its effect on synaptic versus extrasynaptic NMDAR activity.
• To provide evidence for memantine's preferential blockade of pathological NMDAR currents over physiological ones.

Main Methods:

• Utilized rat autaptic hippocampal microcultures.
• Electrophysiological recordings were performed to measure NMDAR-mediated currents.
• Compared memantine's effect on synaptic NMDAR currents (eEPSCs) and extrasynaptic NMDAR currents induced by NMDA/glycine application.

Main Results:

• Memantine (1-10 microM) preferentially blocked extrasynaptic NMDAR currents compared to synaptic NMDAR currents in the same neurons.
• The blockade of extrasynaptic NMDARs was approximately twofold more potent than that of synaptic NMDARs.
• This differential blockade was observed even under conditions mimicking pathological depolarization (1 mM extracellular Mg2+).

Conclusions:

• Memantine's therapeutic tolerability is attributed to its ability to selectively inhibit excessive extrasynaptic NMDAR activity.
• This selective action spares normal synaptic NMDAR function, crucial for physiological neurotransmission.
• Findings offer a clear mechanistic explanation for memantine's clinical safety and efficacy.